Injectable contraception (medroxyprogesterone acetate) in rural Bangladesh.
1601 women used the injectable contraceptive agent medroxyprogesterone acetate for up to 3 years. The programme was conducted by a rural health centre with detailed follow-up. While the continuation-rate, 56% after 1 year, compared favourably with that of other contraceptive methods in Bangladesh, at least half the women experienced troublesome menstrual side-effects and there were indications that milk yield was adversely affected in 147 out of the 1020 women who received the first injection while lactating.
D001459:Bangladesh; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007273:Injections, Intramuscular; D007774:Lactation / Q000187:drug effects; D008525:Medroxyprogesterone / Q000008:administration & dosage* / Q000009:adverse effects; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D010352:Patient Dropouts; D011247:Pregnancy; D012424:Rural Population
D003271:Contraceptive Agents, Female; D008525:Medroxyprogesterone